Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function

Blood

Volumn 106, Issue 12, 2005, Pages 3970-3978

  Pluskota, Elzbieta ^a   Stenina, Olga I ^a   Krukovets, Irene ^a   Szpak, Dorota ^a   Topol, Eric J ^a   Plow, Edward F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; HEAT SHOCK PROTEIN 27; HYDROGEN PEROXIDE; INTEGRIN ALPHAM BETA2; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THROMBOSPONDIN; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE FUNCTION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 28444444138     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-03-1292     Document Type: Article

References (62)

1. Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 2001;104:2641-2644.
2. Clee SM, Zwinderman AH, Engert JC. et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 2001;103:1198-1205.
3. Shimokata K, Yamada Y, Kondo T, et al. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis. 2004;172:167-173.
4. Wessel J, Topol EJ, Ji M, Meyer J, McCarthy JJ. Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. Am Heart J. 2004;147:905-909.
5. Walton B, Willerson JT, Coresh J, Boerwinkle E. Thrombospondin-2 and lymphotoxin-a gene variations predict coronary heart disease in a large prospective study [abstract]. Circulation. 2003;108(suppl 1):IV-771.
6. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347:1916-1923.
7. Kato T, Yamada A, Murase Y, et al. Specific gene polymorphisms could be risk factors for coronary artery disease in individuals with or without hypertension [abstract]. Circulation. 2003;108(suppl 1):IV-712.
8. Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol. 2001;17:25-51.
9. Adams JC, Lawler J. The thrombospondins. Int J Biochem Cell Biol. 2004;36:961-968.
10. Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol. 2004;37:239-240.
11. Lawler J, Duquette M, Whittaker CA, et al. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol. 1993;120:1059-1067.
12. Stenina OI, Desai SY, Krukovets I, et al. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells. Circulation. 2003;108:1514-1519.
13. Adams JC, Lawler J. Adhesive interactions of myoblasts with platelet thrombospondin. Mol Biol Cell. 1994;5:423-437.
14. Arber S, Caroni P. Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth. J Cell Biol. 1995;131:1083-1094.
15. Narouz-Ott L, Maurer P, Nitsche DP, Smyth N, Paulsson M. Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains. J Biol Chem. 2000;275:37110-37117.
16. Berliner S, Rogowski O, Rotstein R, et al. Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology. 2000;94:19-25.
17. Takahashi T, Hato F, Yamane T, et al. Activation of human neutrophil by cytokine-activated endothelial cells. Circ Res. 2001;88:422-429.
18. Huang ZS, Jeng JS, Wang CH, et al. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis. 2001;158:431-436.
19. Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol. 1984;53:997-999.
20. Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.
21. Mehta J, Dinerman J, Mehta P, et al. Neutrophil function in ischemic heart disease. Circulation. 1989;79:549-556.
22. Mehta J, Dinerman J, Mehta P, et al. Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications. Heart. 2000;83:69-75.
23. Stenina OI, Ustinov V, Krukovets I, et al. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. FASEB J. Prepublished on September 7, 2005, as DOI 10.1096/fj.05-3712fje.
24. Pluskota E, Solovjov DA, Plow EF. Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin αMβ2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood. 2003;101:1582-1590.
25. 2 integrins. J Biol Chem. 1996;271:18211-18216.
26. Forsyth CB, Plow EF, Zhang L. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J Immunol. 1998;161:6198-6205.
27. 2. J Biol Chem. 2005;280:1336-1345.
28. Pluskota E, D'Souza SE. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur J Biochem. 2000;267:4693-4704.
29. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
30. Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994;78:1027-1037.
31. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807-869.
32. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55-72.
33. Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal. 2004;16:565-575.
34. 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol. 1994;127:2081-2091.
35. 2 for a specific and high affinity ligand, NIF. J Biol Chem. 1997;272:17558-17564.
36. Dana N, Styrt B, Griffin JD, et al. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986;137:3259-3263.
37. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol. 1989;109:1341-1349.
38. Suchard SJ, Burton MJ, Dixit VM, Boxer LA. Human neutrophil adherence to thrombospondin occurs through a CD11/CD18-independent mechanism. J Immunol. 1991;146:3945-3952.
39. 2 production in adherent human neutrophils. J Immunol. 1994;152:290-300.
40. Majluf-Cruz A, Manns JM, Uknis AB, et al. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays. J Lab Clin Med. 2000;136:292-302.
41. Nathan CF. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest. 1987;80:1550-1560.
42. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood. 1989;73:301-306.
43. Husemann J, Obstfeld A, Febbraio M, Kodama T, Silverstein SC. CD11b/CD18 mediates production of reactive oxygen species by mouse and human macrophages adherent to matrixes containing oxidized LDL. Arterioscler Thromb Vasc Biol. 2001;21:1301-1305.
44. Iwabuchi K, Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood. 2002;100:1454-1464.
45. Ciesla DJ, Moore EE, Biffl WL, et al. Hypertonic saline activation of p38 MAPK primes the PMN respiratory burst. Shock. 2001;16:285-289.
46. Rane MJ, Carrithers SL, Arthur JM, Klein JB, McLeish KR. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase. J Immunol. 1997;159:5070-5078.
47. Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: role of oxidants. J Biol Chem. 1994;269:31234-31242.
48. Walzog B, Weinmann P, Jeblonski F, et al. A role for β2 integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammation response. FASEB J. 1999;13:1855-1865.
49. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor-κB in human neutrophils. J Biol Chem. 2004;279:2657-2665.
50. Dean JL, Brook M, Clark AR, Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem. 1999;274:264-269.
51. Frasch SC, Nick JA, Fadok VA, et al. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem. 1998;273:8389-8397.
52. Detmers PA, Zhou D, Polizzi E, et al. Role of stress-activated mitogen-activated protein kinase (p38) in β2-integrin-dependent neutrophil adhesion and the adhesion dependent oxidative burst. J Immunol. 1998;161:1921-1929.
53. Nick JA, Young SK, Arndt PG, et al. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J Immunol. 2002;169:5260-5269.
54. Gao F, Yue TL, Shi DW, et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res. 2002;53:414-422.
55. Rane MJ, Pan Y, Singh S, et al. Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem. 2003;278:27828-27835.
56. Schmidt A, Caron E, Hall A. Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol Cell Biol. 2001;21:438-448.
57. 2 release in adherent human neutrophils. J Immunol. 1998;160:5154-5162.
58. Stenina OI, Byzova TV, Adams JC, et al. Coronary artery disease and the thrombospondin single nucleotide polymorphisms. Int J Biochem Cell Biol. 2004;36:1013-1030.
59. 2+ binding. J Biol Chem. 2004;279:51915-51922.
60. Chen H, Deere M, Hecht JT, Lawler J. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. J Biol Chem. 2000;275:26538-26544.
61. Calzada MJ, Annis DS, Zeng B, et al. Identification of novel β1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J Biol Chem. 2004;279:41734-41743.
62. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.